Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 24, 2005

View Archived Issues

Antipsychotic effects of a new 5-HT2C receptor agonist from Pfizer

Curcumin and its metabolite highlighted as promising agents for neurologic disorders

JNJ-27291199, an Hdm2:p53 complex inhibitor, potentiates doxorubicin

NSC-67657: A CEBPalpha activator with antileukemic potential

Tanabe updates pipeline progress in H1 FY2005

Oscient files Factive sNDA for five-day treatment of new indications

Pfizer exercises option to NicOx collaborative compounds

Myriad Genetics and Abbott extend pharmacogenetics alliance

First patient enrolled in European phase III trial of Alzhemed

Large multivalent immunogen vaccine active in melanoma, renal cell carcinoma

Tocilizumab study results reveal efficacy in arthritis, systemic lupus erythematosus

Golimumab improves signs and symptoms of refractory rheumatoid arthritis

Oral cFMS kinase inhibitor GW-2580 inhibits CSF-1 signaling in vivo

ALK5 inhibition attenuates profibrotic signaling and fibrogenic response

Flow-induced arterial remodeling modified by cavtratin

Novartis reports novel CCR1 antagonists with activity in experimental arthritis

Clevudine demonstrates sustained activity in chronic hepatitis B patients

Lassa fever vaccine candidate developed

ENMD-1198 to enter clinical testing in 2006

Emergent BioSolutions tests single dose oral typhoid vaccine in Vietnam

Genzyme acquires Cell Genesys' San Diego manufacturing operation

Phase IIb HCV study to evaluate celgosivir plus Pegetron

ChemoCentryx seeks clearance to begin clinical studies of CCX-915

Enrollment begins in phase III Viprinex study for ischemic stroke

Phase III Oxytrex results in moderate to severe osteoarthritic pain

Allergan proposes to acquire Inamed

Xyrem approved to treat excessive daytime sleepiness in narcolepsy patients

Approvable letter for Vasovist

Pexelizumab fails to meet primary endpoint threshold for statistical significance

Recent Merck KGaA patent claims novel anticoagulant agents

Cardiovascular agents disclosed in recent patent literature

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...